---
title: "Ultragenyx Pharma (RARE.US) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/RARE.US/norm.md"
symbol: "RARE.US"
name: "Ultragenyx Pharma"
parent: "https://longbridge.com/en/quote/RARE.US.md"
datetime: "2026-05-20T18:22:08.606Z"
locales:
  - [en](https://longbridge.com/en/quote/RARE.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/RARE.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/RARE.US/norm.md)
---

# Ultragenyx Pharma (RARE.US) — Financial Reports

## Income Statement (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| EPS | -1.84 | -1.29 | -1.81 | -1.17 | -1.57 |
| ROE | 468.35% | 1451.77% | -899.56% | -311.17% | -302.57% |
| Revenue | 136.00M | 207.28M | 159.93M | 166.50M | 139.00M |
| Net income | -185.00M | -128.56M | -180.41M | -114.95M | -151.00M |
| Operating income | -139.00M | -113.28M | -170.89M | -107.89M | -143.00M |
| Gross margin | -27.21% | -12.23% | -52.69% | -12.76% | -25.18% |
| Net margin | -136.03% | -62.02% | -112.81% | -69.04% | -108.63% |
| Profit quality | - | - | - | - | - |

## Balance Sheet (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| A&L | 1.30B | 1.53B | 1.19B | 1.31B | 1.31B |
| Leverage | -5.66 | -20.99 | 73.67 | 8.25 | 8.67 |
| BVPS | -2.41 | -0.8299 | 0.0951 | 1.57 | 1.54 |
| Turnover | 0.5138 | 0.4435 | 0.4618 | 0.4169 | 0.4507 |
| Cash & STI | 413.00M | 680.00M | 425.25M | 487.58M | 494.44M |
| Inv & Rec | 55.00M | 52.00M | 52.20M | 46.50M | 46.03M |
| LT assets | 239.00M | 267.00M | 249.96M | 255.76M | 260.91M |
| Net debt | 666.00M | 515.00M | 415.80M | 343.87M | 326.69M |

## Cash Flow Statement (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | -197.00M | -99.83M | -91.42M | -108.27M | -166.00M |
| Investing CF | -49.00M | -72.25M | 117.18M | 71.17M | 120.00M |
| Financing CF | - | 394.19M | 2000.00 | 83.65M | - |
| Free CF | -77.88M | -38.04M | -3.50M | -56.33M | -114.28M |
| OCF coverage | -19700.00% | -10642.75% | -7153.60% | -4401.34% | -16600.00% |
| Repaid & issued | - | - | - | - | - |
| CapEx | -1.00M | -938000.00 | -1.28M | -2.46M | -1.00M |